LEP and myeloid sarcoma: The current understanding of metabolic syndrome (MS) and diabetes mellitus type 2 (DM2) is that formation of their main components is influenced by the substrate-energy role played by lipocyte products and informational signalling molecules, such as leptin and adiponectin [1].